您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > Methylprednisolone Sodium Succinate
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Methylprednisolone Sodium Succinate
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Methylprednisolone Sodium Succinate图片
CAS NO:2375-03-3
包装与价格:
包装价格(元)
100mg电议
250mg电议
500mg电议
1g电议

产品介绍

化学性质

Physical AppearanceA solid
StorageStore at -20°C
M.Wt496.53
Cas No.2375-03-3
FormulaC26H33NaO8
Solubility≥49.7 mg/mL in DMSO; ≥13.1 mg/mL in EtOH; ≥2.94 mg/mL in H2O
Chemical Namesodium 4-(2-((6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethoxy)-4-oxobutanoate
Canonical SMILESO[C@@]1(C(COC(CCC([O-])=O)=O)=O)[C@](C2)(C)[C@@H](CC1)[C@H](C[C@@H]3C)[C@@H]([C@@](C)(C=C4)C3=CC4=O)[C@H]2O.[Na+]
运输条件蓝冰运输或根据您的需求运输。
一般建议为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同厂家不同批次产品溶解度各有差异,仅做参考。若实验所需浓度过大至产品溶解极限,请添加助溶剂助溶或自行调整浓度。溶液形式一般不宜长期储存,请尽快用完。

资料参考

Methylprednisolone sodium succinate is the sodium succinate ester of methylprednisolone which a synthetic corticosteroid with anti-inflammatory and immunomodulating properties [1].

Methylprednisolone binds to specific nuclear receptors, altering gene expression and reducing proinflammatory cytokine production. Methylprednisolone also decreases the number of circulating lymphocytes, induces cell differentiation, and triggers apoptosis in sensitive tumor cell populations [1].

In human polymorphonuclear leukocytes, methylprednisolone sodium succinate exerted no effect on O2-· production, H2O2 production, or chemiluminescence at low concentrations (0.04 ~ 0.22 mM), but triggered significant inhibition at a high concentration of 2.7 mM [2]. In human neutrophils, methylprednisolone sodium succinate at a high concentration of 1 mg/ml inhibited chemotactic response [3].

In the National Acute Spinal Cord Injury Study, methylprednisolone sodium succinate (30 mg/kg bolus followed by 5.4 mg/kg/h infusion for 23 hours) showed no significant differences against the control group overall at 6 weeks. However, the recovery of motor score and sensory touch score at 6 weeks was slightly, but significantly greater in the methylprednisolone sodium succinate-treated group than the placebo group for those treated within 8 hours of injury [4].

References:

[1]. National Center for Biotechnology Information. PubChem Database. Methylprednisolone, CID=6741, https://pubchem.ncbi.nlm.nih.gov/compound/Methylprednisolone (accessed on July 20, 2020)

[2]. Levine P H, Hardin J C, Scoon K L, et al. Effect of corticosteroids on the production of superoxide and hydrogen peroxide and the appearance of chemiluminescence by phagocytosing polymorphonuclear leukocytes. Inflammation, 1981, 5(1): 19-27.

[3]. Majeski J A, Alexander J W. The steroid effect on the in vitro human neutrophil chemotactic response. Journal of Surgical Research, 1976, 21(4): 265-268.

[4]. Steeves J, Blight A. Chapter 24 - Spinal cord injury clinical trials translational process, review of past and proposed acute trials with reference to recommended trial guidelines. Handbook of Clinical Neurology, 2012, 109: 386-397.